If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.00
Bid: 171.00
Ask: 171.80
Change: 0.00 (0.00%)
Spread: 0.80 (0.468%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 171.00
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of EUR 15 Million Share Buyback Programme

21 Feb 2024 07:00

RNS Number : 8374D
C&C Group Plc
21 February 2024
 

C&C Group plc

Launch of ?15 Million Share Buyback Programme

 

Dublin, London 21 February 2024: C&C Group plc ('C&C' or the 'Group'), owners of the Tennent's, Magners and Bulmers Ireland brands, and Matthew Clark and Bibendum Wine, announces that it will commence a share buyback programme on 1 March 2024 to repurchase ordinary shares of the Group (the "Shares") up to a maximum aggregate consideration of ?15 million (the "Programme").

 

The Programme forms part of the Group's plan to return up to ?150 million to shareholders over the next three fiscal years as announced in October 2023 through a combination of dividends and share buybacks and follows the reinstatement of dividend payments last year. The Programme is underpinned by the Board's confidence in the medium-term outlook for the business and its strong cash generation capabilities. The Board also believes that the Programme represents the most effective use of capital in the current environment.

 

Details of the Programme

The Group has entered into an agreement with J&E Davy ("Davy") to act as principal to conduct the Programme and to repurchase Shares on the Group's behalf for a maximum aggregate consideration of up to ?15 million and to make trading decisions under the Programme in accordance with certain pre-set parameters. Under the terms of the agreement, Davy will make purchases of the Shares under the Programme independently of, and uninfluenced by, the Group.

 

The Programme will commence on 1 March 2024, and end no later than 30 June 2024, subject to market conditions. The purpose of the Programme is to reduce the share capital of the Company in line with this announcement. Under the terms of the Programme, the Shares will be repurchased on the London Stock Exchange and will be cancelled. The Programme will be conducted in accordance with:

 

(i) the Group's general authority to repurchase shares (which authorises the repurchase of up to 40,270,889 Shares, being approximately 10% of the issued share capital of the Group), as approved by shareholders at the Group's AGM held on 13 July 2023 (the "Authority"); and

 

(ii) the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052 (including as each of them forms part of retained EU law in the United Kingdom ("UK") from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the applicable laws and regulations of the UK Financial Conduct Authority.

 

The execution of the Programme may be augmented by the purchase of Shares by way of block trades effected by Davy as agent of the Group. The maximum number of Shares which can be repurchased by the Group under the Programme will be reduced by the corresponding number of Shares repurchased pursuant to any such block trades. Any Shares repurchased through block trades will also count towards the maximum consideration payable by the Group.

 

Details of any Shares repurchased under the Share Buyback Programme will be notified to a Regulatory Information Service by the Group following repurchase. Purchases may continue under the Programme during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

 

There is no guarantee that the Programme will be implemented in full or that any Shares will be bought back by the Group.

 

 

ENDS

 

 

Contacts

 

C&C Group plc Riona Heffernan, Group Finance & Investor Relations Director

Email: riona.heffernan@candcgroup.com

 

Investors, Analysts & Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Aline Oliveira

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 83 833 1644

Email: CandCGroup@fticonsulting.com

 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland. 

C&C Group's portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent's, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUROARSRUUUUR
Date   Source Headline
20th May 20217:00 amRNSDirector/PDMR Shareholding
20th May 20217:00 amRNSDirector Declaration
12th May 20217:00 amRNSHolding(s) in Company
6th May 20217:00 amRNSBlock Listing Application
27th Apr 20217:00 amBUSStatement re Appointment of Independent Non-Executive Director
19th Apr 20214:15 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amBUSStatement re IT security incident affecting Matthew Clark Bibendum Ltd
31st Mar 20213:15 pmRNSTotal Voting Rights
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
16th Mar 20217:00 amBUSTrading Statement
11th Mar 20212:45 pmRNSConfirmation of Migration
2nd Mar 20217:00 amBUSStatement re Notice of Pre-Close Trading Update
26th Feb 20214:30 pmRNSTotal Voting Rights
25th Feb 20217:10 amRNSDirector Declaration
19th Feb 20214:26 pmRNSDirector/PDMR Shareholding
1st Feb 20217:00 amRNSHolding(s) in Company
22nd Jan 20218:38 amRNSHolding(s) in Company
18th Jan 20214:00 pmRNSDirector/PDMR Shareholding
14th Jan 202112:20 pmRNSResult of EGM
21st Dec 20204:41 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSNotice of EGM
2nd Dec 20204:30 pmRNSDirector/PDMR Shareholding
18th Nov 20205:15 pmRNSDirector/PDMR Shareholding
16th Nov 202010:18 amRNSHolding(s) in Company
10th Nov 20204:56 pmRNSHolding(s) in Company
10th Nov 20204:55 pmRNSHolding(s) in Company
4th Nov 20202:15 pmRNSDirector/PDMR Shareholding
30th Oct 20201:49 pmRNSHolding(s) in Company
30th Oct 202011:40 amRNSTotal Voting Rights
29th Oct 20203:28 pmRNSDirector/PDMR Shareholding
29th Oct 20203:27 pmRNSHolding(s) in Company
28th Oct 20205:15 pmRNSDirector/PDMR Shareholding
27th Oct 20202:45 pmRNSDirector/PDMR Shareholding
23rd Oct 20203:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20202:54 pmRNSHolding(s) in Company
21st Oct 20203:00 pmRNSDirector/PDMR Shareholding
21st Oct 20203:00 pmRNSDirector/PDMR Shareholding
21st Oct 20207:00 amBUSHalf-year Report
7th Oct 20207:00 amBUSNotice of Results
30th Sep 20207:00 amRNSTotal Voting Rights
16th Sep 20207:00 amRNSAppointment of Corporate Brokers
2nd Sep 20204:10 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
19th Aug 20202:06 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSConfirmation of CEO Commencement Date
31st Jul 20207:00 amRNSTotal Voting Rights
28th Jul 202010:48 amRNSHolding(s) in Company
23rd Jul 202012:50 pmRNSAGM Results
15th Jul 202011:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.